G01N2333/8132

BLADDER CANCER BIOMARKERS AND METHODS OF USE
20250305057 · 2025-10-02 ·

Compositions, kits, and methods for the prognosis of bladder cancer in a subject are provided by detecting in tumor tissue a combination of biomarkers consisting of ANG, A1AT, APOE, CA9, IL8, MMP9, MMP10, PAI-1, SDC1 and VEFGA.